Edelman MJ - Search Results

1

Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer.

Chiappori A, Williams C, Northfelt DW, Adams JW, Malik S, Edelman MJ, Rosen P, Van Echo DA, Berger MS, Haura EB. Chiappori A, et al. Among authors: edelman mj. J Thorac Oncol. 2014 Jan;9(1):121-5. doi: 10.1097/JTO.0000000000000027. J Thorac Oncol. 2014. PMID: 24346101 Free PMC article. Clinical Trial.

2

Promising new agents in the treatment of non-small cell lung cancer.

Edelman MJ, Gandara DR. Edelman MJ, et al. Cancer Chemother Pharmacol. 1996;37(5):385-93. doi: 10.1007/s002800050402. Cancer Chemother Pharmacol. 1996. PMID: 8599859 Review.

3

Multimodality therapy in stage III non-small cell lung cancer.

Edelman MJ, Gandara DR, Roach M 3rd, Benfield JR. Edelman MJ, et al. Ann Thorac Surg. 1996 May;61(5):1564-72. doi: 10.1016/0003-4975(96)00044-6. Ann Thorac Surg. 1996. PMID: 8633990 Review.

4

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.

Gandara DR, Edelman MJ, Crowley JJ, Lau DH, Livingston RB. Gandara DR, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 1997;41(1):75-8. doi: 10.1007/s002800050710. Cancer Chemother Pharmacol. 1997. PMID: 9443617 Clinical Trial.

5

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

6

Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.

Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Langer CJ, et al. Among authors: edelman mj. Semin Oncol. 1999 Feb;26(1 Suppl 4):12-8. Semin Oncol. 1999. PMID: 10201516 Review.

7

Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.

Gandara DR, Edelman MJ, Lau D. Gandara DR, et al. Among authors: edelman mj. Semin Oncol. 1999 Jun;26(3 Suppl 10):3-7. Semin Oncol. 1999. PMID: 10437743 Review.

8

Phase I study of docetaxel and topotecan in patients with solid tumors.

Tkaczuk KH, Zamboni WC, Tait NS, Meisenberg BR, Doyle LA, Edelman MJ, Hausner PF, Egorin MJ, Van Echo DA. Tkaczuk KH, et al. Among authors: edelman mj. Cancer Chemother Pharmacol. 2000;46(6):442-8. doi: 10.1007/s002800000180. Cancer Chemother Pharmacol. 2000. PMID: 11138457 Clinical Trial.

9

New directions in the treatment of non-small cell lung cancer: an overview.

Edelman MJ. Edelman MJ. Oncologist. 2001;6 Suppl 1:1-3. doi: 10.1634/theoncologist.6-suppl_1-1. Oncologist. 2001. PMID: 11181996 Free article.

10

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.

Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J. Lau D, et al. J Clin Oncol. 2001 Jan 15;19(2):442-7. doi: 10.1200/JCO.2001.19.2.442. J Clin Oncol. 2001. PMID: 11208837 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters